Erratum: Diabetes Eye Screening in Urban Settings Serving Minority Populations: Detection of Diabetic Retinopathy and Other Ocular Findings Using Telemedicine (JAMA Ophthalmology (2015) 133:2 (174-181) (doi:10.1001/jamaophthalmol.2014.4652));Diabetes eye screening in urban settings serving minority populations: Detection of diabetic retinopathy and other ocular findings using telemedicine

JAMA Ophthalmology

Volumn 133, Issue 2, 2015, Pages 174-181

  Owsley, Cynthia ^a   McGwin, Gerald ^a,b   Lee, David J ^c   Lam, Byron L ^d   Friedman, David S ^e   Gower, Emily W ^e,f   Haller, Julia A ^g   Hark, Lisa A ^g   Saaddine, Jinan ^h  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; AGE RELATED MACULAR DEGENERATION; ARTICLE; CATARACT; CAUCASIAN; COTTON WOOL SPOT; CROSS-SECTIONAL STUDY; CUBAN; DIABETIC RETINOPATHY; DISEASE DURATION; EYE EXAMINATION; FEMALE; HAITIAN; HEALTH INSURANCE; HISPANIC; HUMAN; HYPERTENSION RETINOPATHY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; NEVUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; NONMYDRIATIC CAMERA; OPHTHALMIC CAMERA; PRIORITY JOURNAL; PTERYGIUM; RETINA DISEASE; RETINA MACULOPATHY; SCREENING TEST; TELEMEDICINE; TOBACCO; UNITED STATES; URBAN AREA; BLOOD; CLINICAL TRIAL; DISEASE COURSE; EPIDEMIOLOGY; ETHNOLOGY; FOLLOW UP; MASS SCREENING; METABOLISM; MIDDLE AGED; MINORITY GROUP; MULTICENTER STUDY; PREVALENCE; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VISUAL SYSTEM EXAMINATION;

ADULT; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MINORITY GROUPS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; TELEMEDICINE; UNITED STATES; URBAN POPULATION;

EID: 84922901040     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2015.223     Document Type: Erratum

References (59)

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: US Dept of Health and Human Services; 2014. http://www.cdc.gov/diabetes/pubs/statsreport14.htm. Accessed October 10, 2014.
2. Boyle JR Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050. Diabetes Care. 2001;24(11):1936-1940.
3. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JR Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus. Arch Ophthalmol. 2008;126(12):1740-1747.
4. Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649-656.
5. Rein DB, Zhang R Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754-1760.
6. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298(8):902-916.
7. Basch CE, Walker EA, Howard CJ, Shamoon H, Zybert P. The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health. 1999;89(12):1878-1882.
8. Sloan FA, Grossman DS, Lee PP. Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression. Optomology.2009;116(8):1515-1521.
9. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2012. http://one.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-2014. Accessed October 15, 2014
10. Cavallerano J. Optometric Clinical Practice Guideline, Care of the Patient with Diabetes Mellitus, Reference Guide for Clinicians. St Louis, MO. American Optometric Association; 2009. http://www.aoa.org/documents/CPG-3.pdf. Accessed October 7, 2014.
11. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
12. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136(8):565-574.
13. Maclennan PA, McGwin G Jr, Heckemeyer C, et al. Eye care use among a high-risk diabetic population seen in a public hospital's clinics. JAMA Ophthalmol. 2014;132(2):162-167.
14. Pérez CM, Febo-Vázquez I, Guzmán M, Ortiz AP, Suárez E. Are adults diagnosed with diabetes achieving the American Diabetes Association clinical practice recommendations? P R Health Sci J. 2012;31(1):18-23.
15. Paz SH, Varma R, Klein R, Wu J, Azen SP; Los Angeles Latino Eye Study Group. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113(8):1372-1377.
16. Baker RS, Watkins NL, Wilson MR, Bazargan M, Flowers CW Jr. Demographic and clinical characteristics of patients with diabetes presenting to an urban public hospital ophthalmology clinic. Ophthalmology. 1998;105(8):1373-1379.
17. Centers for Disease Control and Prevention. Improving the nation's vision health: a coordinated public health approach. http://www.cdc.gov/visionhealth/pdf/improving-nations-vision-health.pdf. Accessed October 7, 2014.
18. Owsley C, McGwin G, Scilley K, Girkin CA, Phillips JM, Searcey K. Perceived barriers to care and attitudes about vision and eye care: focus groups with older African Americans and eye care providers. Invest Ophthalmol Vis Sci. 2006;47(7): 2797-2802.
19. Maclennan PA, McGwin G Jr, Searcey K, Owsley C. A survey of Alabama eye care providers in 2010-2011. BMC Ophthalmol. 2014;14:44.
20. Rask KJ, Williams MV, Parker RM, McNagny SE. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA. 1994;271(24):1931-1933.
21. Chou C-F, Sherrod CE, Zhang X, et al. Barriers to eye care among people aged 40 years and older with diagnosed diabetes, 2006-2010. Diabetes Care. 2014;37(1):180-188.
22. Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78(4):374-385.
23. Forster AS, Forbes A, Dodhia H, et al. Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study. Diabetes Care. 2013;36(9):2663-2669.
24. Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012;172(21):1677-1678.
25. Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology. 2013;120(12):2604-2610.
26. Zimmer-Galler IE, Zeimer R. Telemedicine in diabetic retinopathy screening. Int Ophthalmol Clin. 2009;49(2):75-86.
27. Silva PS, Cavallerano JD, Aiello LM, Aiello LP. Telemedicine and diabetic retinopathy. Arch Ophthalmol. 2011;129(2):236-242.
28. Wilson RR, Silowash R, Anthony L, Cecil RA, Eller A. Telemedicine process used to implement an effective and functional screening program for diabetic retinopathy. J Diabetes Sci Technol. 2008;2 (5):785-791.
29. Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations. Telemed J E Health. 2013;19(12):942-948.
30. Li HK, Horton M, Bursell S-E, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):1-24.
31. Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening. Am J Ophthalmol. 2002;134(2):204-213.
32. Massin P, Erginay A, Ben Mehidi A, et al. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med. 2003;20(8):635-641.
33. Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2011;129(4):435-444.
34. Ogunyemi O, Terrien E, Eccles A, et al. Teleretinal screening for diabetic retinopathy in six Los Angeles urban safety-net clinics: initial findings. AMIA Annu Symp Proc. 2011;2011:1027-1035.
35. Gibson DM. Eye care availability and access among individuals with diabetes, diabetic retinopathy, or age-related macular degeneration. JAMA Ophthalmol. 2014;132(4):471-477.
36. Nathoo N, Ng M, Rudnisky CJ, Tennant MTS. The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Can J Ophthalmol. 2010;45(1):28-32.
37. Arora S, Kurji AK, Tennant MTS. Dismantling sociocultural barriers to eye care with tele-ophthalmology: lessons from an Alberta Cree community. Clin Invest Med. 2013;36(2):57-63.
38. Cavallerano AA, Conlin PR. Teleretinal imaging to screen for diabetic retinopathy in the Veterans Health Administration. J Diabetes Sci Technol. 2008;2(1):33-39.
39. Maberley D, Morris A, Hay D, Chang A, Hall L, Mandava N. A comparison of digital retinal image quality among photographers with different levels of training using a non-mydriatic fundus camera. Ophthalmic Epidemiol. 2004;11(3):191-197.
40. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010;27(3):249-256.
41. Rein DB, Wittenborn JS, Zhang X, et al; Vision Cost-Effectiveness Study Group. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res. 2011;46(5):1534-1561.
42. Harding S, Greenwood R, Aldington S, et al; Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med. 2003;20(12):965-971.
43. American Academy of Ophthalmology Preferred Practice Patterns Committee. Preferred Practice Pattern Guidelines: Comprehensive Adult Medical Eye Evaluation. San Francisco, CA: American Academy of Ophthalmology; 2010. http://one.aao.org/preferred-practice-pattern/comprehensive-adult-medical-eye-evaluation-octobe. Accessed October 7, 2014.
44. Zimmer-Galler I, Zeimer R. Results of implementation of the DigiScope for diabetic retinopathy assessment in the primary care environment. Telemed J E Health. 2006;12(2):89-98.
45. Cavallerano AA, Cavallerano JD, Katalinic P, et al; Joslin Vision Network Research Team. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center-the Joslin Vision Network Eye Health Care Model. Am J Ophthalmol. 2005;139(4):597-604.
46. An J, Nichol MB. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013;51(10):879-887.
47. 1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357-1362.
48. Gregg EW, Geiss LS, Saaddine J, et al. Use of diabetes preventive care and complications risk in two African-American communities. Am J Prev Med. 2001;21(3):197-202.
49. Flavin NE, Mulla ZD, Bonilla-Navarrete A, et al. Health insurance and the development of diabetic complications. South Med J. 2009;102(8):805-809.
50. Sivaprasad S, Gupta B, Gulliford MC, et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One. 2012;7(3):e32182. doi:10.1371/journal.pone.0032182.
51. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4): 552-563.
52. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446-455.
53. Shin P, Finnegan B. Assessing the need for on-site eye care professionals in community health centers. Policy Brief George Wash Univ Cent Health Serv Res Policy. 2009;(2):1-23.
54. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266(3):369-374.
55. Javitt JC, McBean AM, Nicholson GA, Babish JD, Warren JL, Krakauer H. Undertreatment of glaucoma among black Americans. N Engl J Med. 1991;325(20):1418-1422.
56. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open. 2013;3(11):e003787.
57. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999;6(3):219-228.
58. Olayiwola JN, Sobieraj DM, Kulowski K, St Hilaire D, Huang JJ. Improving diabetic retinopathy screening through a statewide telemedicine program at a large federally qualified health center. J Health Care Poor Underserved. 2011;22(3):804-816.
59. Jiménez-Ramírez F, Pérez R. Diabetic retinopathy education and screening at the community pharmacy in Puerto Rico. P R Health Sci J. 2011;30(3):139-144.